Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results
|
Intellia Therapeutics, Inc. (NTLA)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/25/2023 |
SC 13G
| BlackRock Inc. reports a 8.7% stake in Intellia Therapeutics, Inc. |
02/09/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
07/09/2019 |
SC 13G
| Nikko Asset Management Americas, Inc. reports a 11.3% stake in INTELLIA THERAPEUTICS, INC. |
07/09/2019 |
SC 13G
| Sumitomo Mitsui Trust Holdings, Inc. reports a 11.3% stake in Intellia Therapeutics, Inc. |
02/14/2019 |
SC 13G
| ARK Investment Management LLC reports a 15.7% stake in Intellia Therapeutics, Inc. |
02/13/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/11/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/07/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/28/2017 |
SC 13G
| Caribou Biosciences, Inc. reports a 15.5% stake in Intellia Therapeutics, Inc. |
02/09/2017 |
SC 13G
| Atlas Venture Fund IX, L.P. reports a 12.3% stake in INTELLIA THERAPUTICS, INC. |
06/10/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
05/11/2016 |
SC 13G
| Intellia Therapeutics, Inc. reports a 7.7% stake in Intellia Therapeutics, Inc. |
|
|